Hipertrófiás kardiomiopátia: vizsgálatok itt: Magyarország
1 trial · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleOpen-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
- Where
- Budapest XII, Szeged
- Életkor
- 18 év to 85 év
- People
- 900 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00